Where it is registered
Each register with its number of medicines and a few of them.
All medicines with Meningococcal (a, c, y
Every register, a page at a time. Strengths and packs are on each medicine’s page.
36 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| MenveoCombination | United States | 0.5ML | Injection | Marketed | GlaxoSmithKline Biologicals |
| MenveoCombination | United States | 0.5ML | Injection | Marketed | GlaxoSmithKline Biologicals |
| MenactraCombination | United States | 48UG/.5ML | For Injection | Marketed | Sanofi Vaccines US Inc. |
| Menquadfi | United States | 0.5ML | Injection | Marketed | Sanofi Vaccines US Inc. |
| NimenrixCombination | New Zealand | Inj 5 mcg of each meningococcal polysaccharide conjugated to a total of approximately 44 mcg of tetanus toxoid carrier in 0.5 ml vial | Funded | ||
| PenmenvyCombination | United States | 25UG/0.5ML | Injection | Marketed | GlaxoSmithKline Biologicals |
| PenbrayaCombination | United States | 5UG | Injection | Marketed | Pfizer Ireland Pharmaceuticals Unlimited Company |
| Menveo | European Union | Authorised | GSK Vaccines S.r.l. | ||
| MenQuadfi | European Union | Authorised | Sanofi Winthrop Industrie | ||
| Meningococcal Vaccine A&C VialCombination | Saudi Arabia | Authorised | Sanofi Pasteur | ||
| Meningococcal Vaccine A&C VialCombination | Saudi Arabia | Authorised | Sanofi Pasteur | ||
| Nimenrix | European Union | Authorised | Pfizer Europe MA EEIG | ||
| MenveoCombination | Canada | 47 MCG / 0.5 ML + 10 MCG / 0.5 ML + 5 MCG / 0.5 ML + 5 MCG / 0.5 ML + 5 MCG / 0.5 ML | Powder For Solution, Solution | Marketed | Glaxosmithkline INC |
| MenveoCombination | Canada | 10 MCG / 0.5 ML + 5 MCG / 0.5 ML + 5 MCG / 0.5 ML + 5 MCG / 0.5 ML | Solution | Marketed | Glaxosmithkline INC |
| MenquadfiCombination | Canada | 10 MCG / 0.5 ML + 10 MCG / 0.5 ML + 10 MCG / 0.5 ML + 10 MCG / 0.5 ML + 55 MCG / 0.5 ML | Solution | Marketed | Sanofi Vaccines Canada LTD. |
| MenomuneCombination | United States | 50UG/.5ML | For Injection | Withdrawn | Sanofi Vaccines US Inc. |
| MenhibrixCombination | United States | 0.5ML | Injection | Withdrawn | GlaxoSmithKline Biologicals |
| NimenrixCombination | Canada | 5 MCG / 0.5 ML + 5 MCG / 0.5 ML + 5 MCG / 0.5 ML + 5 MCG / 0.5 ML + 44 MCG / 0.5 ML | Kit, Powder For Solution | Marketed | Pfizer Canada Ulc |
| Menveo Powder and Solution for Solution for InjectionCombination | Singapore | 10 microgram conjugated to 16.7-33.3 microgram + 5 microgram conjudated to 7.1-12.5 microgram + 5 microgram conjugated to 3.3-8.3 microgram + 5 microgram conjugated to 5.6-10 microgram | injection, powder, for solution | Authorised | Glaxosmithkline Pte LTD |
| Menquadfi Solution for InjectionCombination | Singapore | 10 mcg/ 0.5 mL + 10 mcg/ 0.5 mL + 10 mcg / 0.5mL + 10 mcg/ 0.5 mL + 55 mcg/ 0.5 mL | injection, solution | Authorised | Sanofi-Aventis Singapore Pte. LTD. |
| MenQuadfiCombination | New Zealand | Inj 10 mcg of each meningococcal polysaccharide conjugated to a total of approximately 55 mcg of tetanus toxoid carrier per 0.5 ml vial | Funded | ||
| NimenrixCombination | New Zealand | Inj 5 mcg of each meningococcal polysaccharide conjugated to a total of approximately 44 mcg of tetanus toxoid carrier per 0.5 ml vial | Funded | ||
| Menomune-A/C/Y/W-135Combination | Canada | 50 MCG / 0.5 ML + 50 MCG / 0.5 ML + 50 MCG / 0.5 ML + 50 MCG / 0.5 ML | Kit, Powder For Solution | Cancelled | Sanofi Vaccines Canada LTD. |
| Menomune-A/C/Y/W-135Combination | Canada | 2.5 MG / KIT + 2.5 MG / KIT + 2.5 MG / KIT + 2.5 MG / KIT | Powder For Solution | Cancelled | Aventis Pasteur Limited |
| Menomune-A/C/Y/W-135Combination | Canada | 500 MCG / KIT + 500 MCG / KIT + 500 MCG / KIT + 500 MCG / KIT | Powder For Solution | Cancelled | Sanofi Vaccines Canada LTD. |
Brand names
The same brand on several registers.
Sources
Compiled by Prognia from the public medicine registers of PHARMAC. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
At a glance
- Registers
- 1
- Medicines
- 1